Gene · 3161
Papers2,270
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
561 to 580 of 2,270
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| In Silico Analysis of the Correlation of KIF2C with Prognosis and Immune Infiltration in Glioma. | Comput Math Methods Med | 2022 | 35387222 | PubTator, text mining | PubMed |
| The Pro-fibrotic Response of Mesenchymal Leader Cells to Lens Wounding Involves Hyaluronic Acid, Its Receptor RHAMM, and Vimentin. | Front Cell Dev Biol | 2022 | 35386200 | PubTator, text mining | PubMed |
| Antigen-Specific TCR-T Cells for Acute Myeloid Leukemia: State of the Art and Challenges. | Front Oncol | 2022 | 35356211 | PubTator, text mining | PubMed |
| Circular RNA PLCE1 promotes epithelial mesenchymal transformation, glycolysis in colorectal cancer and M2 polarization of tumor-associated macrophages. | Bioengineered | 2022 | 35349390 | PubTator, text mining | PubMed |
| Magnetic Solid Nanoparticles and Their Counterparts: Recent Advances towards Cancer Theranostics. | Pharmaceutics | 2022 | 35335882 | PubTator, text mining | PubMed |
| Identification and validation of Osteopontin and receptor for hyaluronic acid-mediated motility (RHAMM, CD168) for potential immunotherapeutic significance of in lung squamous cell carcinoma. | Int Immunopharmacol | 2022 | 35334357 | PubTator, text mining | PubMed |
| Increasing Role of Targeted Immunotherapies in the Treatment of AML. | Int J Mol Sci | 2022 | 35328721 | PubTator, text mining | PubMed |
| The Role of Epigenetic Modifications in Human Cancers and the Use of Natural Compounds as Epidrugs: Mechanistic Pathways and Pharmacodynamic Actions. | Biomolecules | 2022 | 35327559 | PubTator, text mining | PubMed |
| Impact of Cancer Stem Cells on Therapy Resistance in Gastric Cancer. | Cancers (Basel) | 2022 | 35326607 | PubTator, text mining | PubMed |
| Hyaluronan-mediated motility receptor antisense RNA 1 promotes hepatitis B virus-related hepatocellular carcinoma progression by regulating miR-627-3p/High Mobility Group AT-hook 2 axis. | Bioengineered | 2022 | 35322735 | PubTator, text mining | PubMed |
| Comparison of tumor and two types of paratumoral tissues highlighted epigenetic regulation of transcription during field cancerization in non-small cell lung cancer. | BMC Med Genomics | 2022 | 35313869 | PubTator, text mining | PubMed |
| NcRNA-Mediated High Expression of HMMR as a Prognostic Biomarker Correlated With Cell Proliferation and Cell Migration in Lung Adenocarcinoma. | Front Oncol | 2022 | 35311097 | PubTator, text mining | PubMed |
| Polysaccharide-Zein Composite Nanoparticles for Enhancing Cellular Uptake and Oral Bioavailability of Curcumin: Characterization, Anti-colorectal Cancer Effect, and Pharmacokinetics. | Front Nutr | 2022 | 35308263 | PubTator, text mining | PubMed |
| Deoxynivalenol triggers porcine intestinal tight junction disorder through hijacking SLC5A1 and PGC1α-mediated mitochondrial function. | Food Chem Toxicol | 2022 | 35307453 | PubTator, text mining | PubMed |
| Analysis of the long non-coding RNA and mRNA expression profiles associated with lidocaine-induced neurotoxicity in the spinal cord of a rat model. | Neurotoxicology | 2022 | 35283115 | PubTator, text mining | PubMed |
| Tumor Microenvironment in Acute Myeloid Leukemia: Adjusting Niches. | Front Immunol | 2022 | 35273598 | PubTator, text mining | PubMed |
| OpenCell: Endogenous tagging for the cartography of human cellular organization. | Science | 2022 | 35271311 | PubTator, text mining | PubMed |
| Hyaluronic Acid-Zein Core-Shell Nanoparticles Improve the Anticancer Effect of Curcumin Alone or in Combination with Oxaliplatin against Colorectal Cancer via CD44-Mediated Cellular Uptake. | Molecules | 2022 | 35268597 | PubTator, text mining | PubMed |
| Tumor-Associated Macrophages in Gliomas-Basic Insights and Treatment Opportunities. | Cancers (Basel) | 2022 | 35267626 | PubTator, text mining | PubMed |
| Tumor-Tissue Expression of the Hyaluronic Acid Receptor RHAMM Predicts Histological Transformation in Follicular Lymphoma Patients. | Cancers (Basel) | 2022 | 35267625 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3161/papers?page=29